<p>Jyong Biotech Ltd. (NASDAQ:MENS - 获取免费报告) 的股价在周三的午盘交易中创下 52 周新低。该公司股价最低跌至$2.81，最后交易价为$2.92，成交量为 3192141 股。该股票此前收盘价为$15.40。</p>
<p>获取 <strong>Jyong Biotech</strong> 的提醒：</p>
<h2>分析师升级和降级</h2>
<p>另外，Weiss Ratings 在 10 月 8 日的研究报告中重申了对 Jyong Biotech 股票的 “卖出（e+）” 评级。一位股票研究分析师对该股票给予了卖出评级，根据 MarketBeat 的数据，Jyong Biotech 的共识评级为 “卖出”。</p>
<p><strong>阅读我们关于 MENS 的最新研究报告</strong></p>
<h2>Jyong Biotech 股价下跌 81.0%</h2>
<p>该公司的 50 日移动平均价为$39.02。</p>
<h2>机构投资者对 Jyong Biotech 的看法</h2>
<p>一位机构投资者最近在 Jyong Biotech 股票中购买了新头寸。根据其最近向证券交易委员会（SEC）提交的 13F 文件，BNP Paribas 金融市场在第三季度购买了 Jyong Biotech Ltd. (NASDAQ:MENS - 免费报告) 的股份。该公司购买了 1698 股，价值约 67,000 美元。</p>
<h2>关于 Jyong Biotech</h2>
<p>(获取免费报告)</p>
<p>我们的使命 我们致力于开发和提供一流的创新药物，以满足客户的健康需求。我们希望成为一个受到公众高度尊重的有价值的商业组织。我们是一家以科学为驱动的生物技术公司，总部位于台湾，致力于开发和商业化创新和差异化的新药（植物来源），主要专注于治疗泌尿系统疾病，初步关注美国、欧盟和亚洲市场。</p>
<h2>了解更多</h2>
<ul>
<li>五只我们更看好的股票，胜过 Jyong Biotech</li>
<li>如何知道一只股票是否支付股息以及何时支付</li>
<li>在上涨 35% 后，分析师关注铜业巨头 Freeport 的更多上涨潜力</li>
<li>如何投资保险公司：指南</li>
<li>为什么 SpaceX 的 IPO 可能成为 GOOGL 股票的重大催化剂</li>
<li>3 只小盘股具有巨大的回报潜力</li>
<li>Upwork 能否维持其复苏？看涨和看跌的理由</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 在 Jyong Biotech 吗？</h2>
<p>在考虑 Jyong Biotech 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Jyong Biotech 并不在名单上。</p>
<p>虽然 Jyong Biotech 目前在分析师中被评为卖出评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

MENS

<p>Jyong Biotech (NASDAQ:MENS) 的股票创下 52 周新低，交易价格低至 2.81 美元，较之前的收盘价 15.40 美元下跌。该股票的共识评级为 “卖出”，Weiss Ratings 重申了 “卖出（e+）” 评级。尽管如此，法国巴黎银行金融市场最近在该公司新建了一个头寸。Jyong Biotech 专注于开发用于泌尿系统疾病的创新药物，目标市场包括美国、欧盟和亚洲</p>

<p>Jyong Biotech Ltd. (NASDAQ:MENS - Get Free Report)'s share price hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $2.81 and last traded at $2.92, with a volume of 3192141 shares changing hands. The stock had previously closed at $15.40.</p>
<div class="lb-trans"><p>Jyong Biotech Ltd. (NASDAQ:MENS - 获取免费报告) 的股价在周三的午盘交易中创下 52 周新低。该公司股价最低跌至$2.81，最后交易价为$2.92，成交量为 3192141 股。该股票此前收盘价为$15.40。</p>
</div><p>Get <strong>Jyong Biotech</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Jyong Biotech</strong> 的提醒：</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师升级和降级</h2>
</div><p>Separately, Weiss Ratings reiterated a &#34;sell (e+)&#34; rating on shares of Jyong Biotech in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Jyong Biotech has a consensus rating of &#34;Sell&#34;.</p>
<div class="lb-trans"><p>另外，Weiss Ratings 在 10 月 8 日的研究报告中重申了对 Jyong Biotech 股票的 “卖出（e+）” 评级。一位股票研究分析师对该股票给予了卖出评级，根据 MarketBeat 的数据，Jyong Biotech 的共识评级为 “卖出”。</p>
</div><p><strong>Read Our Latest Research Report on MENS</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 MENS 的最新研究报告</strong></p>
</div><h2>Jyong Biotech Trading Down 81.0%</h2>
<div class="lb-trans"><h2>Jyong Biotech 股价下跌 81.0%</h2>
</div><p>The company has a fifty day moving average of $39.02.</p>
<div class="lb-trans"><p>该公司的 50 日移动平均价为$39.02。</p>
</div><h2>Institutional Investors Weigh In On Jyong Biotech</h2>
<div class="lb-trans"><h2>机构投资者对 Jyong Biotech 的看法</h2>
</div><p>An institutional investor recently bought a new position in Jyong Biotech stock. BNP Paribas Financial Markets purchased a new position in shares of Jyong Biotech Ltd. (NASDAQ:MENS - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,698 shares of the company's stock, valued at approximately $67,000.</p>
<div class="lb-trans"><p>一位机构投资者最近在 Jyong Biotech 股票中购买了新头寸。根据其最近向证券交易委员会（SEC）提交的 13F 文件，BNP Paribas 金融市场在第三季度购买了 Jyong Biotech Ltd. (NASDAQ:MENS - 免费报告) 的股份。该公司购买了 1698 股，价值约 67,000 美元。</p>
</div><h2>About Jyong Biotech</h2>
<div class="lb-trans"><h2>关于 Jyong Biotech</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>OUR MISSION We endeavor to develop and supply first-class innovative drugs to meet our customers' health needs. We seek to be a valuable business organization that is held in high esteem by the public. We are a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU, and Asia.</p>
<div class="lb-trans"><p>我们的使命 我们致力于开发和提供一流的创新药物，以满足客户的健康需求。我们希望成为一个受到公众高度尊重的有价值的商业组织。我们是一家以科学为驱动的生物技术公司，总部位于台湾，致力于开发和商业化创新和差异化的新药（植物来源），主要专注于治疗泌尿系统疾病，初步关注美国、欧盟和亚洲市场。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Jyong Biotech</li>
<li>How to Know if a Stock Pays Dividends and When They Are Paid Out</li>
<li>Post 35% Surge, Analysts Eye More Upside in Copper Giant Freeport</li>
<li>How to Invest in Insurance Companies: A Guide</li>
<li>Why a SpaceX IPO Could Be a Major Catalyst for GOOGL Stock</li>
<li>3 Small Caps With Big Return Potential</li>
<li>Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Jyong Biotech</li>
<li>如何知道一只股票是否支付股息以及何时支付</li>
<li>在上涨 35% 后，分析师关注铜业巨头 Freeport 的更多上涨潜力</li>
<li>如何投资保险公司：指南</li>
<li>为什么 SpaceX 的 IPO 可能成为 GOOGL 股票的重大催化剂</li>
<li>3 只小盘股具有巨大的回报潜力</li>
<li>Upwork 能否维持其复苏？看涨和看跌的理由</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Jyong Biotech Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在 Jyong Biotech 吗？</h2>
</div><p>Before you consider Jyong Biotech, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Jyong Biotech 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jyong Biotech wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Jyong Biotech 并不在名单上。</p>
</div><p>While Jyong Biotech currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Jyong Biotech 目前在分析师中被评为卖出评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Jyong Biotech（NASDAQ:MENS）创下 52 周新低 - 原因如下